Surgery for metastatic cancer of the brain parenchyma has been shown t
o increase length of survival, especially in patients with primary bre
ast cancer, RCC, and lung cancer. The identification of prognostic var
iables common to patients with brain metastases has permitted developm
ent of therapeutic guidelines.